Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies

NCT00038207 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00038207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00038207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2000
Completion date
September 30, 2005
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, osteosarcoma, soft tissue sarcoma, wilms' tumor